U.S. stock futures were mixed on Monday as investors remained on edge, rattled by the spread of the Delta coronavirus variant.
Dow and S&P futures were down 0.34% and 0.16%, respectively, while Nasdaq futures were up 0.06% at the time of writing.
Cellectar Biosciences Inc. (CLRB), Protalix Biotherapeutics Inc. (PLX), and DISH Network Corp. (DISH) are set to report their quarterly earnings before the market opens. Cable ONE Inc. (CABO), Repay Holdings Corp. (RPAY), and ChemoCentryx Inc. (CCXI) will report after the market closes.
Windtree Therapeutics (WINT) was the most active stock in pre-market trading, with 4.51 million shares changing hands at the time of writing. The increased market activity comes on the heels of the company’s reported second-quarter operating loss of $45.4 million compared to an operating loss of $7.9 million recorded in the same quarter last year.
BIT Mining Ltd. (BTCM) was the biggest gainer in the pre-market session, jumping 34.23% at the time of writing. It is still unclear what is causing the stock to pop. The company bills itself as a leading cryptocurrency mining enterprise, with a long-term strategy of creating value in the burgeoning industry.
BioVie (BIVI) was the biggest laggard, going down 34.63% at the time of writing. The sell-off followed the company’s announcement of the pricing of an underwritten public offering of 2.5 million Class A shares at $8 a share.
Appian Corporation (APPN) has reached an agreement to acquire Lana Labs, a process mining software company. They’ve yet to confirm the terms of the agreement. The acquisition will combine Appian’s expertise in low-code process modeling and automation with Lana’s prowess in machine-learning algorithms.
Baidu, Inc. (BIDU) has unveiled the Apolong II, a new generation of multipurpose autonomous minibuses. Apolong II integrates Baidu’s autonomous driving capabilities and Apollo Robotaxi. They also leverage the company’s vehicle-to-everything and 5G remote driving service. The autonomous minibuses are expected to make smart transportation easier for commuters.
DraftKings (DKNG) delivered second-quarter results that topped Wall Street expectations featuring strong growth in revenue and active customers. Net loss came in at $0.26 a share, much better than the net loss of $0.52 a share that the Street expected. Revenue was up 320% to $298 million, beating consensus estimates of $242.4 million.
Twist Bioscience Corp. (TWST) shares fell 10.8% after the synthetic biology and genomics company delivered wider-than-expected net loss in its fiscal third quarter. Net loss landed at $0.82 a share, wider than the net loss of $0.67 reported last year, and worse than the net loss of $0.75 that the Street expected.
Meanwhile, Cinemark Holdings, Inc. (CNK) shares rose 1.9% after the motion picture exhibitor delivered mixed second-quarter financial results. Quarterly revenues surged to $294.7 million, compared to $8.97 million reported in the same quarter last year, beating consensus estimates of $262.75 million. However, the company posted a net loss of $1.19 a share, wider than the loss of $1.07 a share that the Street expected.
